United Therapeutics
UTHR
UTHR
423 hedge funds and large institutions have $8.13B invested in United Therapeutics in 2021 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 150 increasing their positions, 149 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more capital invested
Capital invested by funds: $7.77B → $8.13B (+$362M)
1% more repeat investments, than reductions
Existing positions increased: 150 | Existing positions reduced: 149
37% less call options, than puts
Call options by funds: $46.6M | Put options by funds: $74.3M
Holders
423
Holding in Top 10
15
Calls
$46.6M
Puts
$74.3M
Top Buyers
| 1 | +$131M | |
| 2 | +$81.6M | |
| 3 | +$47.2M | |
| 4 |
Two Sigma Advisers
New York
|
+$39.6M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$32.2M |
Top Sellers
| 1 | -$87.7M | |
| 2 | -$63.8M | |
| 3 | -$61.8M | |
| 4 |
SCM
Scopia Capital Management
New York
|
-$48.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$40M |